-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
text | memory
Calcitonin gene-related peptide (CGRP) is a popular target drug for migraine drug development.
In addition to different indications, the above 7 drugs are also different in usage and frequency of use
With the announcement of major companies' 2021 financial reports, the sales rankings of the above-mentioned CGRP receptor antagonists have also been released, as detailed in the table below
Migraine is a common chronic neurovascular disease with episodic moderate to severe throbbing headache as the main clinical manifestation.
As a new favorite in the field of migraine, CGRP receptor antagonists have undergone great changes in the market structure in 2020 and 2021.